These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6816500)

  • 1. The use of an activated factor IX complex (Autoplex) in the management of haemarthroses in haemophiliacs with antibodies to factor VIII.
    Aronstam A; McLellan DS; Mbatha PS; Wassef M
    Clin Lab Haematol; 1982; 4(3):231-8. PubMed ID: 6816500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of immune responses following 102 infusions of autoplex in 18 hemophilic patients with antibody to factor VIII.
    Laurian Y; Girma JP; Lambert T; Meyer D; Larrieu MJ
    Blood; 1984 Feb; 63(2):457-62. PubMed ID: 6419798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind controlled trial of two dose levels of factor VIII in the treatment of high risk haemarthroses in haemophilia A.
    Aronstam A; Wassef M; Hamad Z; Cartlidge J; McLellan D
    Clin Lab Haematol; 1983; 5(2):157-63. PubMed ID: 6411418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of early haemarthroses in severely affected adolescent haemophiliacs.
    Aronstam A; Browne RS; Wassef M; Hamad Z
    Clin Lab Haematol; 1984; 6(1):9-15. PubMed ID: 6734103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Articular and muscular hemorrhages in hemophilia A with anti-factor VIII antibodies. Treatment with selected batches of PPSB (factor IX concentrate)].
    Verroust F; Moussard C; Allain JP
    Presse Med; 1985 May; 14(19):1073-6. PubMed ID: 3158962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New activated factors IX product in haemophilia.
    Abonstam A; Aston L; Wassef M; Hamad Z
    Lancet; 1980 Dec; 2(8207):1294. PubMed ID: 6108461
    [No Abstract]   [Full Text] [Related]  

  • 7. Double-blind controlled trial of three dosage regimens in treatment of haemarthroses in haemophilia A.
    Aronstam A; Wasssef M; Choudhury DP; Turk PM; McLellan DS
    Lancet; 1980 Jan; 1(8161):169-71. PubMed ID: 6101631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of bleeding patterns on the response of haemophilic haemarthroses to different doses of factor VIII.
    Aronstam A; Wassef M; Hamad Z; McLellan DS
    Clin Lab Haematol; 1981; 3(2):107-12. PubMed ID: 6788433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bilateral prosthesis of the knee in a hemophilia A patient with an inhibitor].
    Lauroua P; Barbier F; Dieu P; Dumora D; Moulinier J
    Ann Fr Anesth Reanim; 1986; 5(2):154-6. PubMed ID: 3089078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial.
    Sjamsoedin LJ; Heijnen L; Mauser-Bunschoten EP; van Geijlswijk JL; van Houwelingen H; van Asten P; Sixma JJ
    N Engl J Med; 1981 Sep; 305(13):717-21. PubMed ID: 6790990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The identification of high risk knee bleeds in adolescents with severe haemophilia A.
    Aronstam A; Wassef M; Hamad Z; Aston DL
    Clin Lab Haematol; 1982; 4(1):17-21. PubMed ID: 6802553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
    Key NS; Aledort LM; Beardsley D; Cooper HA; Davignon G; Ewenstein BM; Gilchrist GS; Gill JC; Glader B; Hoots WK; Kisker CT; Lusher JM; Rosenfield CG; Shapiro AD; Smith H; Taft E
    Thromb Haemost; 1998 Dec; 80(6):912-8. PubMed ID: 9869160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIII.
    Lusher JM; Blatt PM; Penner JA; Aledort LM; Levine PH; White GC; Warrier AI; Whitehurst DA
    Blood; 1983 Nov; 62(5):1135-8. PubMed ID: 6414555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inhibitor coagulant complex (Autoplex) in hemophilia inhibitor patients undergoing synovectomy.
    Hutchinson RJ; Penner JA; Hensinger RN
    Pediatrics; 1983 Apr; 71(4):631-3. PubMed ID: 6601258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor antibodies to factor VIII and factor IX: management.
    Lusher JM
    Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Musculoskeletal bleeding in hemophilia.
    Greer RB; Ballard JO
    Pediatr Ann; 1982 Jun; 11(6):521-4, 526-7. PubMed ID: 6808447
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemophilic arthropathy. Current concepts of pathogenesis and management.
    Arnold WD; Hilgartner MW
    J Bone Joint Surg Am; 1977 Apr; 59(3):287-305. PubMed ID: 849938
    [No Abstract]   [Full Text] [Related]  

  • 18. [Joint bleeding in haemophiliacs receiving substitution treatment as out-patients (author's transl)].
    Barthels M; Gerstel J
    Dtsch Med Wochenschr; 1975 Jul; 100(29):1523-9. PubMed ID: 1149632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of patients with hemophilia A having antibodies to factor VIII].
    Lopaciuk S; Ziemski JM
    Acta Haematol Pol; 1979; 10(2):115-22. PubMed ID: 474044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemophilic arthropathy of the knee joint. Treatment of hemorrhages of the knee-joint and their consequences].
    Landbeck G; Kurme A
    Monatsschr Kinderheilkd (1902); 1970 Feb; 118(2):29-41. PubMed ID: 5522402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.